Navidea CEO resigns

By staff writers

October 28, 2021 -- The CEO of Navidea Biopharmaceuticals, Jed Latkin, has resigned. Latkin and the company are discussing the terms of a severance agreement pursuant to his employment contract.

Three members of the company's board of directors will take over leadership while an executive search firm identifies the next CEO, the company said.

Latkin replaced former CEO Dr. Michael Goldberg in 2018 when Goldberg resigned.

Copyright © 2021

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking